HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].

Abstract
Most of renal cell carcinomas (RCCs) are refractory at the start of chemotherapy. We have demonstrated that the frequently elevated expression of the multidrug resistance gene (MDR) in RCCs is associated with the intrinsic vinca alkaloids and anthracyclines resistance. The preliminary clinical trials using verapamil or amiodarone in combination with vinblastine or doxorubicin to overcome multidrug-resistant (MDR) tumors could not achieve satisfactory results owing to severe cardiovascular toxicities of such reversing agents. In the present study, we studied the sensitizing ability of bis-benzyl-isoquinoline (cepharanthine) and SDB-ethylenediamine (N-1379) in natural MDR kidney cancer cells. Cepharanthine remarkably sensitized vinblastine and doxorubicin sensitivities in those cells with high MDR RNA levels. From a clinical point of view, cepharanthine seems to be a potent and less toxic agent to treat natural MDR kidney cancers.
AuthorsY Kakehi, T Segawa, T Hashimura, O Yoshida
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 38 Issue 11 Pg. 1319-24 (Nov 1992) ISSN: 0018-1994 [Print] Japan
PMID1485588 (Publication Type: Case Reports, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Benzylisoquinolines
  • Ethylenediamines
  • Terpenes
  • N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine
  • Vinblastine
  • cepharanthine
  • Doxorubicin
Topics
  • Alkaloids (pharmacology, therapeutic use)
  • Benzylisoquinolines
  • Carcinoma, Renal Cell (drug therapy, pathology)
  • Doxorubicin (pharmacology)
  • Drug Resistance (genetics)
  • Drug Screening Assays, Antitumor
  • Ethylenediamines (pharmacology, therapeutic use)
  • Female
  • Humans
  • Kidney Neoplasms (drug therapy, pathology)
  • Middle Aged
  • Terpenes (pharmacology, therapeutic use)
  • Tumor Cells, Cultured
  • Vinblastine (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: